During the past decade, Hiroshima University Hospital; Breast Surgery conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hiroshima University Hospital; Breast Surgery" #1 collaborator was "Genentech, Inc." with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hiroshima University Hospital; Breast Surgery" are "Breast Cancer" (2 trials) and "Neoplasm Metastasis" (1 trials). Many other conditions were trialed in "Hiroshima University Hospital; Breast Surgery" in a lesser frequency.

Most popular intervention types in "Hiroshima University Hospital; Breast Surgery" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (2 trials), "Paclitaxel" (2 trials), "Pertuzumab" (2 trials), "Trastuzumab" (2 trials) and "Trastuzumab Emtansine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hiroshima University Hospital; Breast Surgery" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Hiroshima University Hospital; Breast Surgery". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hiroshima University Hospital; Breast Surgery, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hiroshima University Hospital; Breast Surgery, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".